153 related articles for article (PubMed ID: 18208915)
1. Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient.
Kotzalidis GD; de Pisa E; Patrizi B; Savoja V; Ruberto G; Girardi P
J Psychopharmacol; 2008 Jul; 22(5):581-4. PubMed ID: 18208915
[TBL] [Abstract][Full Text] [Related]
2. Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine.
Koga M; Kodaka F; Miyata H; Nakayama K
Acta Psychiatr Scand; 2009 Oct; 120(4):329-31. PubMed ID: 19573048
[TBL] [Abstract][Full Text] [Related]
3. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Zajecka J; Tracy KA; Mitchell S
J Clin Psychiatry; 1997 Jul; 58(7):291-7. PubMed ID: 9269249
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.
Pollack M; Mangano R; Entsuah R; Tzanis E; Simon NM; Zhang Y
Psychopharmacology (Berl); 2007 Oct; 194(2):233-42. PubMed ID: 17589833
[TBL] [Abstract][Full Text] [Related]
5. [Discontinuation of antidepressant serotonergic antidepressant].
Andersen CL; Videbech P
Ugeskr Laeger; 2010 Jan; 172(4):296-8. PubMed ID: 20105399
[TBL] [Abstract][Full Text] [Related]
6. [Delirium during withdrawal of venlafaxine].
van Noorden MS; Vergouwen AC; Koerselman GF
Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1236-7. PubMed ID: 12132141
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal reactions associated with venlafaxine.
Parker G; Blennerhassett J
Aust N Z J Psychiatry; 1998 Apr; 32(2):291-4. PubMed ID: 9588310
[TBL] [Abstract][Full Text] [Related]
8. Newer antidepressants and the discontinuation syndrome.
Haddad P
J Clin Psychiatry; 1997; 58 Suppl 7():17-21; discussion 22. PubMed ID: 9219489
[TBL] [Abstract][Full Text] [Related]
9. Shock-like sensations during venlafaxine withdrawal.
Reeves RR; Mack JE; Beddingfield JJ
Pharmacotherapy; 2003 May; 23(5):678-81. PubMed ID: 12741444
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant discontinuation: a review of the literature.
Lejoyeux M; Adès J
J Clin Psychiatry; 1997; 58 Suppl 7():11-5; discussion 16. PubMed ID: 9219488
[TBL] [Abstract][Full Text] [Related]
11. Treatment of venlafaxine discontinuation symptoms with ondansetron.
Raby WN
J Clin Psychiatry; 1998 Nov; 59(11):621-2. PubMed ID: 9862610
[No Abstract] [Full Text] [Related]
12. [Severe withdrawal symptoms with fever during paroxetine tapering off].
Peeters FP; Zandbergen J
Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1429-31. PubMed ID: 10422558
[TBL] [Abstract][Full Text] [Related]
13. Withdrawal syndrome after discontinuation of venlafaxine.
Agelink MW; Zitzelsberger A; Klieser E
Am J Psychiatry; 1997 Oct; 154(10):1473-4. PubMed ID: 9326838
[No Abstract] [Full Text] [Related]
14. New dosage-reduction regime to avoid paroxetine discontinuation syndrome.
Pacheco Yáñez L; Malo P; Etxebeste M; Aragües E; Medrano J
Can J Psychiatry; 2003 Mar; 48(2):129-30. PubMed ID: 12655918
[No Abstract] [Full Text] [Related]
15. [Severe withdrawal symptoms with fever upon stopping paroxetine].
Vergouwen AC; Kuipers T
Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1794-5; author reply 1795-6. PubMed ID: 10494332
[No Abstract] [Full Text] [Related]
16. Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.
Gitlin MJ
J Clin Psychopharmacol; 1997 Feb; 17(1):66-7. PubMed ID: 9004070
[No Abstract] [Full Text] [Related]
17. [Venlafaxine withdrawal syndrome: report of six cases and review of the literature].
Pinzani V; Giniès E; Robert L; Peyrière H; Abbar M; Blayac JP
Rev Med Interne; 2000 Mar; 21(3):282-4. PubMed ID: 10763190
[TBL] [Abstract][Full Text] [Related]
18. Venlafaxine withdrawal in organic anxiety disorder.
Jhirwal OP; Chakrabarti S
Indian J Med Sci; 2003 Dec; 57(12):559-60. PubMed ID: 14701949
[No Abstract] [Full Text] [Related]
19. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine.
Fava M; Mulroy R; Alpert J; Nierenberg AA; Rosenbaum JF
Am J Psychiatry; 1997 Dec; 154(12):1760-2. PubMed ID: 9396960
[TBL] [Abstract][Full Text] [Related]
20. Syndrome of inappropriate ADH secretion attributed to the serotonin re-uptake inhibitors, venlafaxine and paroxetine.
Meynaar IA; Peeters AJ; Mulder AH; Ottervanger JP
Neth J Med; 1997 Jun; 50(6):243-5. PubMed ID: 9232089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
